secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2022-10-24T23:59:59+00:00
Accession:  0001437749-22-024634
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integrated BioPharma dismisses Friedman LLP and appoints Marcum LLP as auditor after merger
--------------------------------------------------------------------------------

- Friedman LLP combined with Marcum LLP effective September 1, 2022, then operated separately for Integrated BioPharma.
- On October 21, 2022, the Audit Committee ratified the dismissal of Friedman and engagement of Marcum.
- No disagreements or reportable events occurred in the two most recent fiscal years or subsequent interim period.
- Friedman's audit reports for FY2022 and FY2021 were unqualified and not modified as to uncertainty or scope.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774922024634/0001437749-22-024634-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774922024634/inbp20221024_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-024634

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer